Sign in to view content

“Real World” U.S. Outcomes of Anti-VEGF Therapy in Neovascular AMD: Risk of Vision Loss is Greatest in Patients with Better Baseline Visual Acuity

Thomas A. Ciulla, MD, MBA, FASRS

Video
Published 2016

Related

Bartonella Henselae Presenting as a Bilateral Retinochoroiditis: Clinical and Imaging Features, Diagnosis, and Natural Course
John Allen, MD
Annual Meeting Talks
2016
Chorodial Lesions Come and Go Talking of Michelangelo
Rahul N. Khurana, MD, FASRS
Annual Meeting Talks
2016
Differences in Surgical Performance in Peeling the ILM for Macular Holes Between Fellows-in-Training and Experienced Vitreoretinal Surgeons
Robert Gizicki, MD, FRCSC, DABO
Annual Meeting Talks
2016

Category: AMD-Neovascular

See more